CG Oncology, Inc. (CGON)
57.35
+0.93
(+1.65%)
USD |
NASDAQ |
Feb 20, 13:06
CG Oncology EPS Diluted (Quarterly) : -0.5709 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 0.0558 |
| MannKind Corp. | 0.0256 |
| Madrigal Pharmaceuticals, Inc. | -2.566 |
| Denali Therapeutics, Inc. | -0.736 |
| Solid Biosciences, Inc. | -0.4848 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -43.81M |
| Revenue (Quarterly) | 1.666M |
| Total Expenses (Quarterly) | 45.47M |
| Enterprise Value | 3.989B |
| Gross Profit Margin (Quarterly) | -19.63% |
| Profit Margin (Quarterly) | -2.63K% |
| Earnings Yield | -3.46% |
| Normalized Earnings Yield | -3.460 |